Role of cancer stem cell marker CD44 in gastric cancer: A meta-analysis

International Journal of Clinical and Experimental Medicine

Volumn 7, Issue 12, 2014, Pages 5059-5066

  Wang, Wei ^a   Dong, Li Ping ^a   Zhang, Ning ^a   Zhao, Cheng Hai ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

CD44; Gastric cancer; Invasion; Metastasis; Tumorigenesis

Indexed keywords

CD44V6 ANTIGEN; CELL MARKER; HERMES ANTIGEN;

ARTICLE; CANCER STAGING; CANCER STEM CELL; DATA EXTRACTION; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; LYMPH NODE METASTASIS; LYMPHATIC INVASION; META ANALYSIS; PHYSICAL DISEASE BY ETIOLOGY AND PATHOGENESIS; PROTEIN EXPRESSION; RISK; SAMPLE SIZE; STATISTICAL ANALYSIS; STOMACH CANCER; TUMOR VOLUME; VENOUS INVASION;

EID: 84921497152     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Yang L. Incidence and mortality of gastric cancer in China. World J Gastroenterol 2006; 12: 17-20.
3. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990; 61: 1303-13.
4. Screaton GR, Cáceres JF, Mayeda A, Bell MV, Plebanski M, Jackson DG, Bell JI, Krainer AR. Identification and characterization of three members of the human SR family of premRNA splicing factors. EMBO J 1995; 14: 4336-49.
5. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci U S A 1992; 89: 12160-4.
6. Nagano O, Saya H. Mechanism and biological significance of CD44 cleavage. Cancer Sci 2004; 95: 930-5.
7. Ponta H, Sherman L, Herrlich PA. CD44: from adhesion molecules to signaling regulators. Nat Rev Mol Cell Biol 2003; 4: 33-45.
8. Köbel M, Weichert W, Crüwell K, Schmitt WD, Lautenschläger C, Hauptmann S. Epithelial hyaluronic acid and CD44v6 are mutually involved in invasion of colorectal adenocarcinomas and linked to patient prognosis. Virchows Arch 2004; 445: 456-464.
9. Li M, Zhang B, Zhang Z, Liu X, Qi X, Zhao J, Jiang Y, Zhai H, Ji Y, Luo D. Stem cell-like circulating tumor cells indicate poor prognosis in gastric cancer. Biomed Res Int 2014; 2014: 981261.
10. Li K, Dan Z, Nie YQ. Gastric cancer stem cells in gastric carcinogenesis, progression, prevention and treatment. World J Gastroenterol 2014; 20: 5420-6
11. Li H, Guo L, Li JW, Liu N, Qi R, Liu J. Expression of hyaluronan receptors CD44 and RHAMM in stomach cancers: relevance with tumor progression. Int J Oncol 2000; 17: 927-32.
12. da Cunha CB, Oliveira C, Wen X, Gomes B, Sousa S, Suriano G, Grellier M, Huntsman DG, Carneiro F, Granja PL, Seruca R. De novo expression of CD44 variants in sporadic and hereditary gastric cancer. Lab Invest 2010; 90: 1604-14.
13. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-12.
14. Okayama H, Kumamoto K, Saitou K, Hayase S, Kofunato Y, Sato Y, Miyamoto K, Nakamura I, Ohki S, Sekikawa K, Takenoshita S. CD44v6, MMP-7 and nuclear Cdx2 are significant biomarkers for prediction of lymph node metastasis in primary gastric cancer. Oncol Rep 2009; 22: 745-55.
15. Horikawa M, Iinuma H, Inoue T, Ogawa E, Fukushima R. Clinical significance of intraperitoneal CD44 mRNA levels of magnetically separated CD45-negative EpCAM-positive cells for peritoneal recurrence and prognosis in stage II and III gastric cancer patients. Oncol Rep 2011; 25: 1413-20.
16. Chen S, Hou JH, Feng XY, Zhang XS, Zhou ZW, Yun JP, Chen YB, Cai MY. Clinicopathologic significance of putative stem cell marker, CD44 and CD133, in human gastric carcinoma. J Surg Oncol 2013; 107: 799-806.
17. Mayer B, Jauch KW, Günthert U, Figdor CG, Schildberg FW, Funke I, Johnson JP. De-novo expression of CD44 and survival in gastric cancer. Lancet 1993; 342: 1019-22.
18. Müller W, Schneiders A, Heider KH, Meier S, Hommel G, Gabbert HE. Expression and prognostic value of the CD44 splicing variants v5 and v6 in gastric cancer. J Pathol 1997; 183: 222-7.
19. Wakamatsu Y, Sakamoto N, Oo HZ, Naito Y, Uraoka N, Anami K, Sentani K, Oue N, Yasui W. Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer. Pathol Int 2012; 62: 112-9.
20. Kurozumi K, Nishida T, Nakao K, Nakahara M, Tsujimoto M. Expression of CD44 variant 6 and lymphatic invasion: importance to lymph node metastasis in gastric cancer. World J Surg 1998; 22: 853-7; discussion 857-8.
21. Yamaguchi A, Goi T, Yu J, Hirono Y, Ishida M, Iida A, Kimura T, Takeuchi K, Katayama K, Hirose K. Expression of CD44v6 in advanced gastric cancer and its relationship to hematogenous metastasis and long-term prognosis. J Surg Oncol 2002; 79: 230-5.
22. Chen JQ, Zhan WH, He YL, Peng JS, Wang JP, Cai SR, Ma JP. Expression of heparanase gene, CD44v6, MMP-7 and nm23 protein and their relationship with the invasion and metastasis of gastric carcinomas. World J Gastroenterol 2004; 10: 776-82.
23. Liang YZ, Fang TY, Xu HG, Zhuo ZQ. Expression of CD44v6 and Livin in gastric cancer tissue. Chin Med J (Engl) 2012; 125: 3161-5.
24. Kim YS, Chi SG, Kim YW, Park YK, Yoon C. Molecular genetic characterization of alternatively spliced CD44 transcripts in human stomach carcinoma. J Korean Med Sci 1997; 12: 505-13.
25. Chen XY, Wang ZC, Li H, Cheng XX, Sun Y, Wang XW, Wu ML, Liu J. Nuclear translocations of beta-catenin and TCF4 in gastric cancers correlate with lymph node metastasis but probably not with CD44 expression. Hum Pathol 2005; 36: 1294-301.
26. Yoo CH, Noh SH, Kim H, Lee HY, Min JS. Prognostic significance of CD44 and nm23 expression in patients with stage II and stage IIIA gastric carcinoma. J Surg Oncol 1999; 71: 22-8.
27. Xin Y, Grace A, Gallagher MM, Curran BT, Leader MB, Kay EW. CD44V6 in gastric carcinoma: a marker of tumor progression. Appl Immunohistochem Mol Morphol 2001; 9: 138-42.
28. Chong JM, Fukayama M, Hayashi Y, Funata N, Takizawa T, Koike M, Muraoka M, Kikuchi-Yanoshita R, Miyaki M, Mizuno S. Expression of CD44 variants in gastric carcinoma with or without Epstein-Barr virus. Int J Cancer 1997; 74: 450-4.
29. Cao L, Hu X, Zhang J, Liang P, Zhang Y. CD44+ CD324- expression and prognosis in gastric cancer patients. J Surg Oncol 2014; [Epub ahead of print].
30. Qiu Y, Hu Y, Zhang ZY, Ye L, Xu FH, Schneider ME, Ma XL, Du YX, Zuo XB, Zhou FS, Chen G, Xie XS, Zhang Y, Xia HZ, Wu JF, Du WD. Genetic association of osteopontin (OPN) and its receptor CD44 genes with susceptibility to Chinese gastric cancer patients. J Cancer Res Clin Oncol 2014; [Epub ahead of print].
31. Gallatin WM, Weissman IL, Butcher EC. A cell-surface molecule involved in organ-specific homing of lymphocytes. Nature 1983; 304: 30-4.
32. Idzerda RL, Carter WG, Nottenburg C, Wayner EA, Gallatin WM, St John T. Isolation and DNA sequence of a cDNA clone encoding a lymphocyte adhesion receptor for high endothelium. Proc Natl Acad Sci U S A 1989; 86: 4659-63.
33. Günthert U, Hofmann M, Rudy W, Reber S, Zöller M, Haussmann I, Matzku S, Wenzel A, Ponta H, Herrlich P. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991; 65: 13-24.